Indeed, during this time, the non-stabilization group experienced deterioration of whole-body insulin sensitivity (Matsuda index) and hepatic insulin resistance (HOMA-IR), in contrast to the relative stability of these measures in the stabilization group (Fig. 1E, F). The gene discussed is INS; the disease is Insulin resistance.